XML 50 R29.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial instruments which are measured at fair value on a recurring basis (in millions):
June 30, 2023Level 1Level 2Level 3Total
Assets    
Cash equivalents$635.0 $— $— $635.0 
Available-for-sale investments:
Corporate debt securities
— 830.9 — 830.9 
Asset-backed securities
— 252.5 — 252.5 
United States government and agency securities— 98.4 — 98.4 
Municipal securities
— 2.6 — 2.6 
Investments held for deferred compensation plans125.3 — — 125.3 
Derivatives— 63.9 — 63.9 
$760.3 $1,248.3 $— $2,008.6 
Liabilities    
Derivatives$— $17.8 $— $17.8 
Other liability— — 14.0 14.0 
$— $17.8 $14.0 $31.8 
December 31, 2022    
Assets    
Cash equivalents$280.4 $— $— $280.4 
Available-for-sale investments:
Corporate debt securities
— 980.3 — 980.3 
Asset-backed securities
— 366.6 — 366.6 
United States government and agency securities37.1 94.5 — 131.6 
Municipal securities
— 2.5 — 2.5 
Investments held for deferred compensation plans112.1 — — 112.1 
Derivatives— 65.5 — 65.5 
$429.6 $1,509.4 $— $1,939.0 
Liabilities    
Derivatives$— $27.2 $— $27.2 
Contingent consideration liabilities— — 26.2 26.2 
Other liability— — 14.0 14.0 
$— $27.2 $40.2 $67.4 
Schedule of Changes in Fair Value of Contingent Consideration Obligation The following tables summarize the changes in fair value of the contingent consideration and the other liability (in millions):
 Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2022
$26.2 $14.0 $40.2 
Changes in fair value(26.2)— (26.2)
Balance at June 30, 2023$— $14.0 $14.0 
Contingent ConsiderationOther liabilityTotal
Balance at December 31, 2021
$62.0 $14.0 $76.0 
Changes in fair value(23.8)— (23.8)
Balance at June 30, 2022$38.2 $14.0 $52.2